EP1675818A1 - Method for synthesis of acrylamide derivatives - Google Patents

Method for synthesis of acrylamide derivatives

Info

Publication number
EP1675818A1
EP1675818A1 EP04775567A EP04775567A EP1675818A1 EP 1675818 A1 EP1675818 A1 EP 1675818A1 EP 04775567 A EP04775567 A EP 04775567A EP 04775567 A EP04775567 A EP 04775567A EP 1675818 A1 EP1675818 A1 EP 1675818A1
Authority
EP
European Patent Office
Prior art keywords
aqueous phase
acrylic acid
agmatine
extraction
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP04775567A
Other languages
German (de)
French (fr)
Other versions
EP1675818B1 (en
Inventor
Mattias Algotsson
Philippe Busson
Nicolas Thevenin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
GE Healthcare Bio Sciences AB
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences AB, GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences AB
Publication of EP1675818A1 publication Critical patent/EP1675818A1/en
Application granted granted Critical
Publication of EP1675818B1 publication Critical patent/EP1675818B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines

Definitions

  • the present invention relates to a method for synthesis of acrylamide derivatives, preferably immobilines.
  • the method is especially suitable for synthesis of the immobiline acrylamido agmatine but may be used for synthesis of any acrylamide derivative.
  • the compounds synthesised by the method can be used in the production of a separation material.
  • a preferred example is a separation material for separating amphoteric compounds based on differences in isoelectric points (pi), in particular by electrophoresis (isoelectric focusing, IEF).
  • IEF isoelectric focusing
  • the substances to be separated are typically bio-organic and encompass primarily compounds having polypeptide structure and/or carbohydrate structure. Proteins are particularly important.
  • the carrier material has been functionalized with groups which provide conditions that are beneficial for the intended separation.
  • groups which provide conditions that are beneficial for the intended separation.
  • One important kind of groups has been pH-buffering groups.
  • pH-buffering groups By immobilising pH-buffering groups of different pKa's between the anode end and the cathode end of an electropho- retic gel it became possible during the late seventies to set up immobilised pH-gradients (Aminkemi, US 4,130,470) to be used in isoelectric focusing.
  • In order to have good pH- gradients it was important to have a range of different pH-buffering groups with increasing/ decreasing pKa values spaced within a desired pH-interval.
  • the difference between the pKa of two neighbouring buffering groups has typically been 1-2 pH units.
  • a charged carrier material in WO 02/25264 (Amersham Biosciences) having improved stability against hydrolysis at pH > 10 for the manufacture of separation materials.
  • This document describes (1) properly selecting immobilised pH-buffering groups amongst those that have (a) a pH-dependent charge on a nitrogen atom which binds to an sp -hybridised carbon atom, and (b) a pKa > 9.5, e.g. > 10.0 or > 10.5 or > 11.0, and/or (2) utilising carrier materials, which have been based on certain acryl monomers.
  • Immobilines are acrylamide derivatives with buffering groups. Immobilines are weak acids or bases defined by their pK value. A preferred use of the immobilines is for 2D electrophoresis.
  • One of the most interesting immobilines is acrylamido agmatine.
  • the synthesis of acrylamido agmatine as described in WO 02/25264 involves the reaction of agmatine sulphate and barium hydroxide in water. Thereafter, the formed precipitate of barium sulphate has to be removed by filtration and desalted agmatine is obtained by freeze drying of the aqueous phase.
  • Acrylamido agmatine has a theoretical pKa value of 13.52 and suitable for preparation of separation materials for separation in pH intervals extending 10.
  • the present invention relates to a simple method for synthesis of any acrylamide derivatives, preferably immobilines, which method avoids the above mentioned drawbacks. Furthermore, the invention relates to a method for production of new acrylamide de- 5 rivatives (immobilines) which fill the gaps in the previously known immobiline family.
  • a preferred immobiline produced with the method of the invention is acrylamido agmatine.
  • the method of the invention is applicable to any acrylamide derivative, especially for production of hydrophilic immobilines with high pKa, such as pKa > 10.
  • the immobilines are used in an isoelectric focusing separation material containing an immobilised pH gradient.
  • the separation material comprises immobilines, produced by the method of the invention, for defining at least a part of the pH interval of the gradient.
  • the gradient/interval extends to pH > 10 with immobilines hav-
  • the electrophoretic separation method is 2D electrophoresis.
  • the present invention provides a general method for synthesis of any acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aque- >0 ous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.
  • Preferred acrylamide derivatives are immobilines.
  • a preferred immobiline is acrylamido agmatine.
  • For production of acrylamido agmatine it is preferred to start with an agmatine salt, preferably with agmatine sulphate.
  • the extraction in step c) is done with an organic solvent, pref- erably with methyl isobutyl ketone (MIBK).
  • MIBK methyl isobutyl ketone
  • the acrylic acid derivative is an activated acrylic acid derivative selected from the group acryloyl chloride, acrylic acid N-hydroxysuccinimide ester, pentafluorophenyl acrylate, pentachlorophenylacrylate, 4-nitrophenyl acrylate, etc.
  • the desalting of agmatine sulphate or any other salt of a nu- cleophilic amine is with any organic base, preferably triethylamine (TEA) and diisopro- pylethylamine (DIPEA), or any inorganic base, preferably sodium hydroxide (NaOH) and potassium carbonate (K 2 C0 3 ).
  • organic base preferably triethylamine (TEA) and diisopro- pylethylamine (DIPEA)
  • any inorganic base preferably sodium hydroxide (NaOH) and potassium carbonate (K 2 C0 3 ).
  • the method further comprises fixing pH to about 7.
  • the method comprises, before step b), i) basification of aqueous phase to a pH above the pKa of the organic base, and ii) extraction of aqueous phase with an organic solvent to remove the organic base.
  • agmatine sulphate is dissolved, de- salted with K 2 CO 3 and the method comprises the following steps: a) addition of acryloyl chloride; b) acidification to pH 1-4, preferably pH 2.3; c) filtration d) extraction with MIBK; e) pH adjustment to pH 7
  • the method according to the invention offers multiple variations in the choice of the different components and is ruled by the type of free amine which has to be coupled to acryloyl chloride or any activated acrylic acid derivative (acrylic acid N- hydroxysuccinimide ester, pentafluorophenyl acrylate, pentachlorophenyl acrylate, 4- nitrophenyl acrylate, etc).
  • the method according to the invention offers novel opportunities for the preparation of acrylamide derivatives.
  • a specific application is the preparation of immobilines for 2D electrophoresis which is shown in the experimental part below. Immobilines with high pKa value are especially interesting.
  • the method is not limited to immobiline production but can be used for other purposes involving preparation of acrylamide derivatives.
  • acrylamides are based on unsubstituted and/or N-alkyl substituted acrylamides or methacrylamides.
  • the aqueous phase (about 40 ml) was then extracted with MIBK (methyl isobutyl ketone)(3 times 80 ml) to remove excess acrylic acid formed during the reaction.
  • MIBK methyl isobutyl ketone
  • the traces of MIBK were evaporated on a rotary evaporator to yield the product in water. The yield was at least 50%.
  • the water could be removed by freeze-drying but this increased the risk of homopolymerisation of the acrylamido agmatine.
  • the final white powder can be dissolved in isopropanol and filtered to remove the polymer eventually formed and the salts still present in the aqueous phase.
  • the water could be removed by freeze-drying but this increased the risk of homopolymerisation of the acrylamidoagmatine.
  • the final white powder can be dissolved in isopropanol and filtered to remove the polymer eventually formed and the salts still present in the aqueous phase.
  • K 2 C0 3 Using K 2 C0 3 as a base is the best mode to perform the invention.
  • Agmatine sulphate (2.28g, 10 mmol) was dissolved in distilled water (5 ml) in a round-bottom flask (50 ml) equipped with a magnetic stirrer.
  • K 2 C0 3 (4.14 g, 30 mmol), dissolved in distilled water (5 ml), was added to the round-bottom flask. The reaction mixture was cooled down on an ice-bath and the mixture was stirred for 10 minutes at 5°C.
  • a preferred use is for immobiline production, especially acrylamido agmatine, see above.
  • the immobilines are used in, for example, production of 2D gels.
  • the acrylamide derivatives can be used in the production of chroma- tographic beads and other chromatographic supports.
  • a further use of acrylamide derivatives are as flocculating agents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase. In a preferred embodiment the acryl amide derivative is an immobiline, preferably acrylamido agmatine. The preferred use of the immobilines is for production of 2D gels.

Description

METHOD FOR SYNTHESIS OF ACRYLAMIDE DERIVATIVES
Technical field The present invention relates to a method for synthesis of acrylamide derivatives, preferably immobilines. The method is especially suitable for synthesis of the immobiline acrylamido agmatine but may be used for synthesis of any acrylamide derivative. The compounds synthesised by the method can be used in the production of a separation material. A preferred example is a separation material for separating amphoteric compounds based on differences in isoelectric points (pi), in particular by electrophoresis (isoelectric focusing, IEF). Another preferred example is a separation material for 2D electrophoresis.
Background In two-dimensional, 2D, electrophoresis substances are separated in two dimensions. In the first dimension, the substances are separated by isolectric focusing. Isoelectric focusing is often followed by a second dimension of gel electrophoresis in which each separated substance is further separated according to molecular weight and/or molecular size. Isoelectric focusing and gel electrophoresis is typically run in two dimensions which are perpendicular to each other. 2D electrophoresis can be run both in analytical and preparative amounts of substances to be separated.
The substances to be separated are typically bio-organic and encompass primarily compounds having polypeptide structure and/or carbohydrate structure. Proteins are particularly important.
In certain kinds of electrophoresis the carrier material has been functionalized with groups which provide conditions that are beneficial for the intended separation. One important kind of groups has been pH-buffering groups. By immobilising pH-buffering groups of different pKa's between the anode end and the cathode end of an electropho- retic gel it became possible during the late seventies to set up immobilised pH-gradients (Aminkemi, US 4,130,470) to be used in isoelectric focusing. In order to have good pH- gradients it was important to have a range of different pH-buffering groups with increasing/ decreasing pKa values spaced within a desired pH-interval. The difference between the pKa of two neighbouring buffering groups has typically been 1-2 pH units. For pH intervals extending above pH 10 there has been described a charged carrier material in WO 02/25264 (Amersham Biosciences) having improved stability against hydrolysis at pH > 10 for the manufacture of separation materials. This document describes (1) properly selecting immobilised pH-buffering groups amongst those that have (a) a pH-dependent charge on a nitrogen atom which binds to an sp -hybridised carbon atom, and (b) a pKa > 9.5, e.g. > 10.0 or > 10.5 or > 11.0, and/or (2) utilising carrier materials, which have been based on certain acryl monomers.
Immobilines are acrylamide derivatives with buffering groups. Immobilines are weak acids or bases defined by their pK value. A preferred use of the immobilines is for 2D electrophoresis. One of the most interesting immobilines is acrylamido agmatine. The synthesis of acrylamido agmatine as described in WO 02/25264 involves the reaction of agmatine sulphate and barium hydroxide in water. Thereafter, the formed precipitate of barium sulphate has to be removed by filtration and desalted agmatine is obtained by freeze drying of the aqueous phase. To get rid of most of the barium sulphate, a precipi- tation has to be repeated at least once.Next step is redissolving desalted agmatine in an organic solvent and addition of acryloyl chloride and a base. The reaction is time consuming and often gives of poor yield and purity. Furthermore, the work-up of the reaction mixture often faces difficulties to remove the base and the excess of unreacted acryloyl chloride (often hydrolysed to acrylic acid during the course of reaction).
Acrylamido agmatine has a theoretical pKa value of 13.52 and suitable for preparation of separation materials for separation in pH intervals extending 10. Brief description of the invention The present invention relates to a simple method for synthesis of any acrylamide derivatives, preferably immobilines, which method avoids the above mentioned drawbacks. Furthermore, the invention relates to a method for production of new acrylamide de- 5 rivatives (immobilines) which fill the gaps in the previously known immobiline family.
A preferred immobiline produced with the method of the invention is acrylamido agmatine. However, the method of the invention is applicable to any acrylamide derivative, especially for production of hydrophilic immobilines with high pKa, such as pKa > 10. ιo Preferably, the immobilines are used in an isoelectric focusing separation material containing an immobilised pH gradient. The separation material comprises immobilines, produced by the method of the invention, for defining at least a part of the pH interval of the gradient. Preferably, the gradient/interval extends to pH > 10 with immobilines hav-
15 ing pKa > 9.5, e.g. > 10.0 or > 10.5 or > 11.0, being included. Preferably, the electrophoretic separation method is 2D electrophoresis.
The present invention provides a general method for synthesis of any acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aque- >0 ous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.
!5 Preferred acrylamide derivatives are immobilines. A preferred immobiline is acrylamido agmatine. For production of acrylamido agmatine it is preferred to start with an agmatine salt, preferably with agmatine sulphate.
io In a preferred embodiment the extraction in step c) is done with an organic solvent, pref- erably with methyl isobutyl ketone (MIBK).
The acrylic acid derivative is an activated acrylic acid derivative selected from the group acryloyl chloride, acrylic acid N-hydroxysuccinimide ester, pentafluorophenyl acrylate, pentachlorophenylacrylate, 4-nitrophenyl acrylate, etc.
According to the invention the desalting of agmatine sulphate or any other salt of a nu- cleophilic amine is with any organic base, preferably triethylamine (TEA) and diisopro- pylethylamine (DIPEA), or any inorganic base, preferably sodium hydroxide (NaOH) and potassium carbonate (K2C03).
In a preferred embodiment the method further comprises fixing pH to about 7. In an alternative embodiment the method comprises, before step b), i) basification of aqueous phase to a pH above the pKa of the organic base, and ii) extraction of aqueous phase with an organic solvent to remove the organic base.
According to the preferred method of the invention agmatine sulphate is dissolved, de- salted with K2CO3 and the method comprises the following steps: a) addition of acryloyl chloride; b) acidification to pH 1-4, preferably pH 2.3; c) filtration d) extraction with MIBK; e) pH adjustment to pH 7
Detailed description of the invention The novel method for synthesis of acrylamide derivatives according to the invention is solving all the problems within prior art such as problem with reproducibility and prob- lems related to health aspects. According to the invention NaOH, TEA , DIPEA or K2C03 was used as base to desalt the starting material and to capture as well the proton liberated during the reaction between acryloyl chloride and the desalted starting material. The work-up of the reaction was improved giving high purity, high yield and allowing an easy scaling-up. The excess of acryloyl chloride, which is necessary for the reaction to proceed to excellent yield and which hydrolyses to acrylic acid during the course of reaction, is removed from the aqueous phase by extraction using MIBK after acidification of the aqueous phase. This synthetic approach can be easlily applied to the preparation of other immobilines for which the contaminating acrylic acid is a critical parameter when using those materials for preparation of 2D electrophoresis gels.
The method according to the invention offers multiple variations in the choice of the different components and is ruled by the type of free amine which has to be coupled to acryloyl chloride or any activated acrylic acid derivative (acrylic acid N- hydroxysuccinimide ester, pentafluorophenyl acrylate, pentachlorophenyl acrylate, 4- nitrophenyl acrylate, etc).
The method according to the invention offers novel opportunities for the preparation of acrylamide derivatives. A specific application is the preparation of immobilines for 2D electrophoresis which is shown in the experimental part below. Immobilines with high pKa value are especially interesting.
However, the method is not limited to immobiline production but can be used for other purposes involving preparation of acrylamide derivatives. Examples of acrylamides are based on unsubstituted and/or N-alkyl substituted acrylamides or methacrylamides.
The invention will now be illustrated with a number of non-limiting patent examples. The invention is defined in more details in the appending claims. E X P E R I M E N T A L P A R T I. Synthesis of acrylamidoagmatine
The chemical structure of acrylamido agmatine is shown in Figure 1.
Figure 1
A. Using NaOH as a base
Agmatine sulphate (2.28g, 10 mmol) was dissolved in distilled water (20 ml) in a three- necked round-bottom flask (50 ml) equipped with a magnetic stirrer and a pH meter. The reaction mixture was cooled down on an ice-bath.
For desalting, sodium hydroxide (NaOH) (1M) was added to the round-bottomed flask until pH = 12 was obtained. Acryloyl chloride (1.36g, 1.22 ml, 15 mmol), dissolved in acetone (5 ml), was added drop wise to the flask. The pH of the reaction mixture was maintained at 11.8 during the addition of the acryloyl chloride solution using NaOH (1M). The reaction was allowed to proceed at RT for 2 h. The stirring was then stopped. The pH of the aqueous phase was then fixed to pH 2.5 by addition of concentrated sulphuric acid. The aqueous phase (about 40 ml) was then extracted with MIBK (methyl isobutyl ketone)(3 times 80 ml) to remove excess acrylic acid formed during the reaction. The traces of MIBK were evaporated on a rotary evaporator to yield the product in water. The yield was at least 50%.
B. Using TEA as a base
Agmatine sulphate (2.28g, 10 mmol) was dissolved in distilled water (15 ml) in a round- bottom flask (50 ml) equipped with a magnetic stirrer. Triethylamine (TEA) (3.52 ml, 25 mmol) was added to the round-bottom flask. The reaction mixture was cooled down on an ice-bath and the mixture was stirred for 10 minutes at 5°C. Acryloyl chloride (1.36g, 1.29 ml, 15 mmol), dissolved in acetone (5 ml), was added drop wise to the flask using a Pasteur-pipette. The reaction was allowed to proceed at 5°C for lh. The stirring was then stopped. K2C03 was added to the round-bottom flask until the pH was settled to 11. The volume of the aqueous phase was then 75 ml. The aqueous phase was then extracted with MIBK (2 times 150 ml) to remove TEA. The pH of the aqueous phase was then fixed to pH 2.3 by addition of concentrated sulphuric acid. The aqueous phase was then extracted with MIBK (3 times 150 ml) to remove excess acrylic acid formed during the reaction. The pH of the aqueous phase was then fixed to pH 7 by addition of K2C03. The yield was at least 95%.
Optionally, the water could be removed by freeze-drying but this increased the risk of homopolymerisation of the acrylamido agmatine. However, if this step is performed, the final white powder can be dissolved in isopropanol and filtered to remove the polymer eventually formed and the salts still present in the aqueous phase.
C. Using DIPEA as a base Agmatine sulphate (2.28g, 10 mmol) was dissolved in distilled water (10 ml) in a round- bottom flask (50 ml) equipped with a magnetic stirrer. Diisopropylethyldiamine (DIPEA) (3.88 g, 5.23 ml, 20 mmol) was added to the round-bottom flask together with acetone (10ml). The reaction mixture was cooled down on an ice-bath and the mixture was stirred for 10 minutes at 5°C. Acryloyl chloride (1.81g, 1.625 ml, 20 mmol), dissolved in ace- tone (5 ml), was added drop wise to the flask using a Pasteur-pipette. The reaction was allowed to proceed at 5°C for lh. The stirring was then stopped. K2C03 was added to the round-bottom flask until the pH was settled to 12. The volume of the aqueous phase was then 75 ml. The aqueous phase was then extracted with MIBK (2 times 150 ml) to remove DIPEA. The pH of the aqueous phase was then fixed to pH 2.3 by addition of con- centrated sulphuric acid. The aqueous phase was then extracted with MIBK (3 times 150 ml) to remove excess acrylic acid formed during the reaction. The pH of the aqueous phase was then fixed to pH 7 by addition of K2C03. The yield was at least 95%.
Optionally, the water could be removed by freeze-drying but this increased the risk of homopolymerisation of the acrylamidoagmatine. However, if this step is performed, the final white powder can be dissolved in isopropanol and filtered to remove the polymer eventually formed and the salts still present in the aqueous phase.
D. Using K2C03 as a base Using K2C03 as a base is the best mode to perform the invention. Agmatine sulphate (2.28g, 10 mmol) was dissolved in distilled water (5 ml) in a round-bottom flask (50 ml) equipped with a magnetic stirrer. K2C03 (4.14 g, 30 mmol), dissolved in distilled water (5 ml), was added to the round-bottom flask. The reaction mixture was cooled down on an ice-bath and the mixture was stirred for 10 minutes at 5°C. Acryloyl chloride (1.81g, 1.625 ml, 20 mmol), dissolved in acetone (5 ml), was added drop wise to the flask using a Pasteur-pipette. The reaction was allowed to proceed at 5°C for lh. The stirring was then stopped. The aqueous phase was then fixed to pH 2.3 with concentrated sulphuric acid and filtered on a glass filter. The aqueous phase was then extracted with MIBK (2 times 100 ml) to remove excess acrylic acid formed during the reaction. The pH of the aqueous phase was then fixed to pH 7 by addition of K2C03. The yield was at least 95%.
Optionally, the water could be removed by freeze-drying but this increased the risk of homopolymerisation of the acrylamido agmatine. However, if this step is performed, the final white powder can be dissolved in isopropanol and filtered to remove the polymer eventually formed and the salts still present in the aqueous phase.
II. Use of acrylamide derivatives produced according to the invention
A preferred use is for immobiline production, especially acrylamido agmatine, see above. The immobilines are used in, for example, production of 2D gels.
The invention also relates to use of acrylamide derivatives as carriers in other electropho- retic applications.
Furthermore, the acrylamide derivatives can be used in the production of chroma- tographic beads and other chromatographic supports. A further use of acrylamide derivatives are as flocculating agents.

Claims

1. A method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.
2. A method according to claim 1, wherein the acryl amide derivative is an immobiline.
3. A method according to claim 2, wherein the acrylamide derivative is acrylamido agmatine.
4. A method according to claim 3, wherein the salt is an agmatine salt.
5. A method according to any of the above claims, wherein the extraction in step c) is performed with an organic solvent.
6. A method according to claim 5, wherein the organic solvent is MIBK (methyl isobu- tyl ketone).
7. A method according to any of the above claims, wherein the acrylic acid derivative is an activated acrylic acid derivative selected from the group acryloyl chloride, acrylic acid N-hydroxysuccinimide ester, pentafluorophenyl acrylate, pentachloro- phenylacrylate, 4-nitrophenyl acrylate.
8. A method according to any of the above claims, wherein the desalting is with NaOH, TEA (triethylamine), DIPEA (diisopropylethylamine), or K2C03.
9. A method according to any of the above claims, further comprising fixing pH to 7.
10. A method according to any of the above claims, comprising , before step b), i) basification of aqueous phase to a pH above the pKa of the organic base, and ii) extraction of aqueous phase with an organic solvent to remove the organic base.
11. A method according to any of the claims 1-9, wherein agmatine sulphate is dissolved, desalted with K2C03 and comprising the following steps a) addition of acryloyl chloride; b) acidification to pH 1-4, preferably pH 2.3 c) filtration; d) extraction with MIBK; and e) pH adjustment to pH 7.
EP04775567.3A 2003-10-23 2004-10-18 Method for synthesis of acrylamido agmatine Expired - Lifetime EP1675818B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302827A SE0302827D0 (en) 2003-10-23 2003-10-23 Method for synthesis of acrylamide derivatives
PCT/SE2004/001498 WO2005040092A1 (en) 2003-10-23 2004-10-18 Method for synthesis of acrylamide derivatives

Publications (2)

Publication Number Publication Date
EP1675818A1 true EP1675818A1 (en) 2006-07-05
EP1675818B1 EP1675818B1 (en) 2014-12-03

Family

ID=29546643

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04775567.3A Expired - Lifetime EP1675818B1 (en) 2003-10-23 2004-10-18 Method for synthesis of acrylamido agmatine

Country Status (8)

Country Link
US (1) US7294743B2 (en)
EP (1) EP1675818B1 (en)
JP (1) JP5057782B2 (en)
CN (1) CN1871205B (en)
AU (1) AU2004284024B2 (en)
CA (1) CA2542206C (en)
SE (1) SE0302827D0 (en)
WO (1) WO2005040092A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008872A2 (en) * 2006-07-14 2008-01-17 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
EP2294118B1 (en) 2008-05-30 2012-07-04 3M Innovative Properties Company Method of making ligand functionalized substrates
JP2011523965A (en) 2008-05-30 2011-08-25 スリーエム イノベイティブ プロパティズ カンパニー Ligand functionalized substrate
US8377672B2 (en) 2010-02-18 2013-02-19 3M Innovative Properties Company Ligand functionalized polymers
BR112012021943B1 (en) 2010-03-03 2021-09-28 3M Innovative Properties Company METHOD OF SEPARATION OF A TARGET BIOLOGICAL SPECIES FROM A FLUID
CN109824575A (en) * 2019-03-28 2019-05-31 辽宁靖帆新材料有限公司 A kind of acrylamide derivative and its preparation method and application

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE422371B (en) 1975-12-12 1982-03-01 Aminkemi Ab SET TO GENERATE A PH FUNCTION FOR ELECTROPHORES USE
JPS5692254A (en) * 1979-12-27 1981-07-25 Asahi Chem Ind Co Ltd Purification of unsaturated amide aqueous solution
JP2830210B2 (en) * 1989-11-17 1998-12-02 日本曹達株式会社 Synthesis of α, β-unsaturated ketones
JPH05331122A (en) * 1992-06-03 1993-12-14 Ajinomoto Co Inc Production of n-substituted @(3754/24)meth)acrylamide
US5369142A (en) * 1993-01-15 1994-11-29 The Ohio State University Water soluble polymers containing amino acid residues for dental restoratives
JP2904038B2 (en) * 1994-01-13 1999-06-14 住友化学工業株式会社 Process for producing 4,6-diaminoresorcinol and its precursor
JPH0940624A (en) * 1995-05-23 1997-02-10 Kao Corp Process for producing N-long chain acylamino acid or salt thereof
SE0003358D0 (en) 2000-09-19 2000-09-19 Amersham Pharm Biotech Ab Charged carrier material and its use
JP3823721B2 (en) * 2000-11-28 2006-09-20 東亞合成株式会社 Extraction and recovery method of polymerization inhibitor
JP2003040853A (en) * 2001-05-25 2003-02-13 Ajinomoto Co Inc Method for producing guanidine derivative containing amido group and for salt thereof
SE0104386D0 (en) * 2001-12-21 2001-12-21 Amersham Biosciences Ab Novel monomers useful in the preparation of separation matrices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005040092A1 *

Also Published As

Publication number Publication date
AU2004284024B2 (en) 2011-03-03
CA2542206C (en) 2013-04-23
CA2542206A1 (en) 2005-05-06
JP5057782B2 (en) 2012-10-24
EP1675818B1 (en) 2014-12-03
CN1871205B (en) 2011-12-21
CN1871205A (en) 2006-11-29
WO2005040092A1 (en) 2005-05-06
JP2007509139A (en) 2007-04-12
AU2004284024A1 (en) 2005-05-06
US20070106090A1 (en) 2007-05-10
SE0302827D0 (en) 2003-10-23
US7294743B2 (en) 2007-11-13

Similar Documents

Publication Publication Date Title
EP1675818B1 (en) Method for synthesis of acrylamido agmatine
WO2008139204A2 (en) Functional group imprinted polymers
Styron et al. Alternating stereoregular head, tail–tail, head‐poly (alkylene D‐glucaramides) derived from a homologous series of symmetrical diamido‐di‐d‐glucaric acid monomers
CN103113509A (en) Regeneration-type affinity precipitation agent by using L-thyroxine as affinity ligand, preparation method and application thereof and relevant regeneration-type polymer
CN107892710B (en) A supported platinum complex oxidant that is easy to recover and recycle and its preparation method and application
US20050040109A1 (en) Method of separation of small molecules from aqueous solutions
US20050113539A1 (en) Novel monomers useful in the preparation of separation matrices
EP0367886B1 (en) Hydrophilic monomers, polymers thereof and their applications
KR870000918B1 (en) Process for preparing n-( -glycidoxyalkyl)-substituted amide compounds
ES3032107B2 (en) ORGANIC MOLECULAR CONTAINER FOR THE REMOVAL OF SURFACTANTS FROM LIQUIDS
JP3413898B2 (en) Polymer compound and method for producing the same
JP4167296B2 (en) Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method for producing the same, and acrylamide compound
DE19805431A1 (en) Heteroaromatic oligoamides as affinity ligands
WO1997041093A1 (en) Methods for the synthesis of fmoc protected amines
JP4403020B2 (en) Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method for producing the same, and acrylamide compound
JPH0699377B2 (en) Polyacrylamide gels for improved detection of proteins
US20030173220A1 (en) Charged carrier material and its use
CN102276761A (en) Monosubstituted ammonium positive charge-beta-cyclodextrin and preparation method thereof
JP5128341B2 (en) Amidine-carboxylic acid terphenyl aggregate having aldehyde group and process for producing the same
JP3472800B2 (en) Alkadiin carboxylate
JP2000344834A (en) Polymer compound having temperature response
JPH11335306A (en) Optically resolving agent and optical resolution using the same
CN120682175A (en) A method for preparing chiral non-natural β-amino acid
JPH054045A (en) Liquid chromatographic packing material for optical resolution
JPH0583526B2 (en)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060320

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GE HEALTHCARE BIO-SCIENCES AB

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20091112

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602004046266

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C07C0231020000

Ipc: C07C0277080000

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 277/08 20060101AFI20140328BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140616

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 699265

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602004046266

Country of ref document: DE

Effective date: 20150115

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20141203

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 699265

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150403

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602004046266

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

26N No opposition filed

Effective date: 20150904

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151018

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151031

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151031

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20041018

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141203

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602004046266

Country of ref document: DE

Owner name: CYTIVA SWEDEN AB, SE

Free format text: FORMER OWNER: GE HEALTHCARE BIO-SCIENCES AB, UPPSALA, SE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230824

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230821

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230822

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 602004046266

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20241017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20241017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20241017